A Multicenter, Open-Label Trial of Belinostat in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma - Belinostat PTCL

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2008
This article has no abstract
Epistemonikos ID: 6f9047b33997ce652dc0ed847c2bcfeabe89fa8f
First added on: Apr 17, 2025